Heart rate slowing by If current inhibition

著者

volume editors, A. John Camm, Michal Tendera

（Advances in cardiology, v. 43）

Karger, c2006

Includes bibliographical references and indexes

Heart rate: a risk factor for cardiac diseases and outcomes? Pathophysiology of cardiac diseases and the potential role of heart rate slowing / Lanza, G.A., Fox, K., Crea, F.
If current inhibition: cellular basis and physiology / Mangoni, M.E., Marger, L., Nargeot, J.
Heart rate reduction by pharmacological If current inhibition / Cargnoni, A. ... [et al.]
Clinical perspectives of heart rate slowing for coronary event reduction and heart failure / Danchin, N., Kadri, Z.
Clinical effect of 'pure' heart rate slowing with a prototype If current inhibitor: placebo-controlled experience with ivabradine / Borer, J.S.
Heart rate slowing versus other pharmacological antianginal strategies. Results of comparative studies / Diaz, A., Tardif, J.-C.
Novel If current inhibitor ivabradine: safety considerations / Savelieva, I., Camm, A.J.
Heart rate slowing for myocardial dysfunction/heart failure. Rationale and preclinical studies / Mulder, P., Thuillez, C.
Future directions: what data do we need? / Tendera, M